Viewing Study NCT00924105


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2026-06-14 @ 9:32 PM
Study NCT ID: NCT00924105
Status: COMPLETED
Last Update Posted: 2012-02-13
First Post: 2009-06-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes
Sponsor: Cytos Biotechnology AG
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords: